A novel BRCA1 mutation in a Spanish patient with ovarian cancer

被引：1

作者：

Salgado, Josefa ^{[1
]}

Gil, Carmen ^{[1
]}

Robles, Maitane ^{[1
]}

Garcia-Foncillas, Jesus ^{[1
,2
]}

机构：

[1] Univ Navarra Clin, Clin Genet Unit, Navarra, Spain

[2] Ctr Appl Med Res CIMA, Lab Pharmacogenom, Navarra, Spain

来源：

BREAST CANCER RESEARCH AND TREATMENT | 2009年 / 113卷 / 01期

关键词：

BRCA1; Direct automatic sequencing; Germline mutation; Ovarian cancer; BINDING; SUSCEPTIBILITY; COMPLEX;

D O I：

10.1007/s10549-008-9907-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We report a novel germline 3536delT mutation in BRCA1 gene, detected in a 43-year-old woman with bilateral ovarian adenocarcinoma. The mutation originates a premature stop codon at position 1154 and has not been documented in any published report to the best of our knowledge.

引用

页码：71 / 73

页数：3

共 50 条

[31] BRCA1 mutation presenting with primary breast, ovarian and colon cancer
Masood, Ashiq
Hudhud, Kanan H.
Hegazi, A. Zakaria
Gupta, N. C.
AMERICAN JOURNAL OF CASE REPORTS, 2008, 9 : 338 - 341
[32] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
Leendert H Zaaijer
Helena C van Doorn
Marian J E Mourits
Marc van Beurden
Joanne A de Hullu
Muriel A Adank
Luc R C W van Lonkhuijzen
Hans F A Vasen
Brigitte F M Slangen
Katja N Gaarenstroom
Ronald P Zweemer
Peggy M L H Vencken
Caroline Seynaeve
Mieke Kriege
British Journal of Cancer, 2016, 115 : 1174 - 1178
[33] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
Zaaijer, Leendert H.
van Doorn, Helena C.
Mourits, Marian J. E.
van Beurden, Marc
de Hullu, Joanne A.
Adank, Muriel A.
van Lonkhuijzen, Luc R. C. W.
Vasen, Hans F. A.
Slangen, Brigitte F. M.
Gaarenstroom, Katja N.
Zweemer, Ronald P.
Vencken, Peggy M. L. H.
Seynaeve, Caroline
Kriege, Mieke
BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1174 - 1178
[34] A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer
Da Li
Fang-Fang Bi
Na-Na Chen
Ji-Min Cao
Wu-Ping Sun
Yi-Ming Zhou
Chun-Yan Li
Qing Yang
Scientific Reports, 4
[35] A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer
Li, Da
Bi, Fang-Fang
Chen, Na-Na
Cao, Ji-Min
Sun, Wu-Ping
Zhou, Yi-Ming
Li, Chun-Yan
Yang, Qing
SCIENTIFIC REPORTS, 2014, 4
[36] De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation
Tesoriero, A
Andersen, C
Southey, M
Somers, G
McKay, M
Armes, J
McCredie, M
Giles, G
Hopper, JL
Venter, D
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (02) : 567 - 569
[37] Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers
Milne, Roger L.
Antoniou, Antonis C.
ENDOCRINE-RELATED CANCER, 2016, 23 (10) : T69 - T84
[38] Weight gain and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Kim, Shana
Lubinski, Jan
Huzarski, Tomasz
Moller, Pal
Armel, Susan
Karlan, Beth
Senter, Leigha
Eisen, Andrea
Foulkes, William
Singer, Christian
Tung, Nadine
Bordeleau, Louise
Neuhausen, Susan
Olopade, Olufunmilayo
Eng, Charis
Weitzel, Jeffrey
Fruscio, Robert
Narod, Steven
Kotsopoulos, Joanne
MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S357 - S358
[39] Large genome rearrangement of BRCA1/2 in BRCA mutation negative ovarian cancer patients
Kim, M. H.
Jung, H. J.
Kim, B. J.
Kim, H.
Park, S. I.
Ryu, S. Y.
EUROPEAN JOURNAL OF CANCER, 2022, 174 : S99 - S99
[40] Contraceptive use and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
Xia, Yue Yin
Lubinski, Jan
Rosen, Barry
Moller, Pal
Eisen, Andrea
Ainsworth, Peter
Senter, Leigha
Neuhausen, Susan
Singer, Christian
Brooks, Jennifer
Sun, Ping
Narod, Steven
Kotsopoulos, Joanne
MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S50 - S51

← 1 2 3 4 5 →